* Inari Medical Inc NARI.OQ reported a quarterly adjusted loss
of 6 cents per share for the quarter ended in September. The
mean expectation of six analysts for the quarter was for a loss
of 11 cents per share.
* Revenue rose 88.3% to $72.92 million from a year ago;
analysts expected $63.03 million.
* Inari Medical Inc's reported EPS for the quarter was a loss
of 6 cents.
* The mean earnings estimate of analysts had fallen by
about 3,203.3% in the last three months.
* In the last 30 days three analysts negatively revised earnings
estimates
* Inari Medical Inc shares had risen by 7.5% this quarter and
lost 0.1% so far this year.
* The company reported a quarterly loss of $2.8 million.
* Wall Street's median 12-month price target for Inari Medical
Inc is $119.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated November 9 at 10:02 p.m.
All figures in US dollars unless otherwise stated